Nanobiotix SA
F:5NRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nanobiotix SA
F:5NRA
|
FR |
|
RH
NYSE:RH
|
US |
|
R
|
Rheinmetall AG
SWB:RHM
|
DE |
|
V
|
Volkswagen AG
OTC:VWAPY
|
DE |
|
Tyler Technologies Inc
NYSE:TYL
|
US |
|
B
|
Brinker International Inc
F:BKJ
|
US |
|
K
|
KT Alpha Co Ltd
KOSDAQ:036030
|
KR |
|
Enterprise Products Partners L.P
NYSE:EPD
|
US |
|
Macfarlane Group PLC
LSE:MACF
|
UK |
|
Exor NV
AEX:EXO
|
NL |
|
Grupo Aeroportuario del Sureste SAB de CV
OTC:ASRMF
|
MX |
|
Grupo Aeroportuario del Sureste SAB de CV
F:AED
|
MX |
|
Arcosa Inc
NYSE:ACA
|
US |
|
A
|
Acrow Ltd
F:59Y
|
AU |
|
Spok Holdings Inc
NASDAQ:SPOK
|
US |
Bankruptcy Probability
Nanobiotix SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Nanobiotix SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Nanobiotix SA
PAR:NANO
|
1.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
466.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
63.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Nanobiotix SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Nanobiotix SA has total debt of 91m EUR. This includes both short-term (0 EUR) and long-term (91m EUR) debt.
You can find a full breakdown on its Balance Sheet.